fda warning letter compounding semaglutide news Guest Letter: Concerns About Compounded GLP-1 Medications | STOP Obesity Alliance | Milken Institute School of Public Health September 8, 2025: FDA launches

Inflammation and Alzheimers disease

et al (2021) Arf1 orchestrates Rab GTPase conversion at the trans-Golgi network

The result tempers claims that DSIP functions as a cortisol-lowering 'anti-stress' peptide in humans and underscores how limited and inconsistent the controlled human endocrine data for DSIP remain

Leptin levels fell during weight loss and increased brain activity in areas involved in emotional, cognitive, and sensory control of food intake

This point of view is also supported by phylogeny, as the presence of a GB appears to be a primitive trait

Ferroptosis: mechanisms and implications for cancer development and therapy response